DK1608336T3 - Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler - Google Patents

Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Info

Publication number
DK1608336T3
DK1608336T3 DK04757846T DK04757846T DK1608336T3 DK 1608336 T3 DK1608336 T3 DK 1608336T3 DK 04757846 T DK04757846 T DK 04757846T DK 04757846 T DK04757846 T DK 04757846T DK 1608336 T3 DK1608336 T3 DK 1608336T3
Authority
DK
Denmark
Prior art keywords
formulation
hydrofluoracanes
propellants
dosing inhaler
inhaler
Prior art date
Application number
DK04757846T
Other languages
English (en)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1608336T3 publication Critical patent/DK1608336T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK04757846T 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler DK1608336T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
PCT/US2004/008375 WO2004084858A2 (en) 2003-03-20 2004-03-19 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants

Publications (1)

Publication Number Publication Date
DK1608336T3 true DK1608336T3 (da) 2008-06-02

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04757846T DK1608336T3 (da) 2003-03-20 2004-03-19 Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler

Country Status (28)

Country Link
US (1) US7914770B2 (da)
EP (1) EP1608336B1 (da)
JP (1) JP4708332B2 (da)
KR (1) KR101113003B1 (da)
CN (1) CN1761455A (da)
AT (1) ATE390125T1 (da)
AU (1) AU2004224367B2 (da)
BR (1) BRPI0408547A (da)
CA (1) CA2519523C (da)
CO (1) CO5640070A2 (da)
CY (1) CY1108137T1 (da)
DE (1) DE602004012718T2 (da)
DK (1) DK1608336T3 (da)
EA (1) EA009087B1 (da)
EC (1) ECSP056029A (da)
ES (1) ES2304616T3 (da)
HR (1) HRP20050822B1 (da)
ME (1) ME00420B (da)
MX (1) MXPA05009920A (da)
NO (1) NO336457B1 (da)
NZ (1) NZ542957A (da)
PL (1) PL1608336T3 (da)
PT (1) PT1608336E (da)
RS (1) RS51663B (da)
SI (1) SI1608336T1 (da)
UA (1) UA89751C2 (da)
WO (1) WO2004084858A2 (da)
ZA (1) ZA200506463B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
DK1809243T4 (da) * 2004-07-02 2022-09-05 Boehringer Ingelheim Int Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
AU2008289109B2 (en) * 2007-08-17 2012-02-02 Centrexion Therapeutics Corporation High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
UA121114C2 (uk) 2014-05-07 2020-04-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх Небулайзер, індикаторний пристрій і контейнер
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
ES2954961T3 (es) 2014-05-07 2023-11-27 Boehringer Ingelheim Int Unidad, nebulizador y método
EP3280393A1 (en) * 2015-04-10 2018-02-14 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) * 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
WO1994013262A1 (en) * 1992-12-09 1994-06-23 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
JP3588113B2 (ja) * 1993-04-30 2004-11-10 ミネソタ マイニング アンド マニュファクチャリング カンパニー エアゾール缶用シール構成
DE69412626T2 (de) * 1993-07-15 1999-01-28 Minnesota Mining & Mfg Dichtungen für eine vorrichtung zum abgeben eines aerosols
NZ306281A (en) * 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
GB9513084D0 (en) * 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) * 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
DE60239806D1 (de) 2001-06-26 2011-06-01 Norton Healthcare Ltd Verbesserter aerosol-regler

Also Published As

Publication number Publication date
PT1608336E (pt) 2008-04-21
WO2004084858A3 (en) 2004-11-04
CA2519523A1 (en) 2004-10-07
KR20050111382A (ko) 2005-11-24
CA2519523C (en) 2012-03-13
NO20054839L (no) 2005-10-19
EA009087B1 (ru) 2007-10-26
RS20050705A (en) 2008-04-04
CO5640070A2 (es) 2006-05-31
DE602004012718D1 (de) 2008-05-08
WO2004084858A2 (en) 2004-10-07
CY1108137T1 (el) 2014-02-12
DE602004012718T2 (de) 2009-05-07
NZ542957A (en) 2008-09-26
KR101113003B1 (ko) 2012-02-24
JP2006520797A (ja) 2006-09-14
US7914770B2 (en) 2011-03-29
UA89751C2 (ru) 2010-03-10
CN1761455A (zh) 2006-04-19
EA200501363A1 (ru) 2006-04-28
RS51663B (en) 2011-10-31
SI1608336T1 (sl) 2008-08-31
ES2304616T3 (es) 2008-10-16
AU2004224367A1 (en) 2004-10-07
AU2004224367B2 (en) 2009-10-08
ZA200506463B (en) 2006-04-26
ME00420B (me) 2011-12-20
HRP20050822A2 (en) 2006-10-31
NO336457B1 (no) 2015-08-31
PL1608336T3 (pl) 2008-09-30
US20040184994A1 (en) 2004-09-23
HRP20050822B1 (hr) 2013-09-30
ECSP056029A (es) 2006-01-27
EP1608336A2 (en) 2005-12-28
EP1608336B1 (en) 2008-03-26
ATE390125T1 (de) 2008-04-15
MXPA05009920A (es) 2005-11-04
BRPI0408547A (pt) 2006-03-07
JP4708332B2 (ja) 2011-06-22

Similar Documents

Publication Publication Date Title
DK1608336T3 (da) Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler
EA200700042A1 (ru) РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
EA200401304A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
BRPI0412320A (pt) uso de um agente modificador de reologia, e composições de revestimento
ECSP045491A (es) Nueva sal formiato de o-desmetil venlafaxina
SE0301653D0 (sv) Novel compounds
BRPI0412310A (pt) uso de um agente controlador de reologia, agente modificador de reologia, concentrados, e, composições com reologia melhorada
RS51616B (en) HETEROARYL UREE DERIVATIVES USEFUL TO INHIBIT CHK1
NO20052557D0 (no) Morfolinderivater for bruk som dopamin-agonister i behandling av blant annet seksuell dysfunksjon.
DK1583756T3 (da) Thiophencarboxamider som inhibitorer af enzymet IKK-2
WO2006089954A3 (en) Compounds for stabilizing factor vii polypeptide formulations
ECSP056231A (es) Fluorbutenos nematicidas que contienen tiazolina
EA200501698A1 (ru) Противовспенивающие композиции
CL2004001579A1 (es) Composicion farmaceutica que comprende un analogo de somatostatina y acido tartarico, donde la composicion tiene el ph regulado entre 4 y 4,5 y el compuesto activo es l ciclo[{4-(nh2-c2h4-nh-cp-o)pro}-phg-dtrp-lys-tyr(4-bzl)-phe]; y su uso para prepa
DE50201777D1 (de) Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit
WO2006047233A3 (en) Pink-1 promoter
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
DE60324816D1 (de) Impfstoffe gegen allergien
SE0702711L (sv) Ny kemisk substans lämplig för användning som mjukgörare i sprängämnes- och drivmedelsblandningar
ATE400618T1 (de) Pulver-überzugsmittelzusammensetzung
ECSP077378A (es) Isoxazoles sustituidos como fungicidas
DK1575559T3 (da) Doseringsaerosoler med lecithin som overfladeaktivt stof